Who are Passiflora, Crataegus e Salix's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Passiflora ; Crataegus and Salix, Sinupret extract coated tablets, BNO 1016, Cimicifuga + Hiperico.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/passiflora-crataegus-e-salix.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Passiflora, Crataegus e Salix — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Passiflora, Crataegus e Salix (Passiflora, Crataegus e Salix) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination / Phytotherapeutic. Area: Cardiovascular / Psychiatry.

phase 3 Herbal combination / Phytotherapeutic Cardiovascular / Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Passiflora, Crataegus e Salix (Passiflora, Crataegus e Salix) — Ativus Farmaceutica Ltda. This herbal combination product works through the synergistic anxiolytic, cardiotonic, and anti-inflammatory properties of its three plant constituents to promote cardiovascular and nervous system health.

Comparator set (4 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Passiflora, Crataegus e Salix TARGET	Passiflora, Crataegus e Salix	Ativus Farmaceutica Ltda	phase 3	Herbal combination / Phytotherapeutic
Passiflora ; Crataegus and Salix	Passiflora ; Crataegus and Salix	Marjan Industria e Comercio ltda	phase 3	Herbal combination / Phytotherapeutic agent
Sinupret extract coated tablets	Sinupret extract coated tablets	Bionorica SE	phase 3	Herbal combination / phytotherapeutic agent
BNO 1016	BNO 1016	Bionorica SE	phase 3	Herbal combination / Phytotherapeutic agent
Cimicifuga + Hiperico	Cimicifuga + Hiperico	Phytopharm Consulting Brazil	phase 3	Herbal combination / phytotherapeutic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination / Phytotherapeutic class)

Ativus Farmaceutica Ltda · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Passiflora, Crataegus e Salix — Competitive Intelligence Brief. https://druglandscape.com/ci/passiflora-crataegus-e-salix. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing